(Q30881997)

27 June 2017

title

Purification and characterization of a new recombinant factor VIII (N8). (English)

1 reference

27 June 2017

0 references

L Thim

1

1 reference

27 June 2017

B Vandahl

2

1 reference

27 June 2017

J Karlsson

3

1 reference

27 June 2017

N K Klausen

4

1 reference

27 June 2017

J Pedersen

5

1 reference

27 June 2017

T N Krogh

6

1 reference

27 June 2017

M Kjalke

7

1 reference

27 June 2017

J M Petersen

8

1 reference

27 June 2017

L B Johnsen

9

1 reference

27 June 2017

G Bolt

10

1 reference

27 June 2017

P L Nørby

11

1 reference

27 June 2017

T D Steenstrup

12

1 reference

27 June 2017

publication date

11 November 2009

1 reference

27 June 2017

1 reference

27 June 2017

volume

16

1 reference

27 June 2017

issue

2

1 reference

27 June 2017

page(s)

349-359

1 reference

describes a project that uses

27 June 2017

F435

0 references

cites work

Characterization of the human factor VIII gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Analysis of the site-specific asparagine-linked glycosylation of recombinant human coagulation factor VIIa by glycosidase digestions, liquid chromatography, and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Structural and functional characterization of B-domain deleted recombinant factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Acidic residues C-terminal to the A2 domain facilitate thrombin-catalyzed activation of factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Production processes of licensed recombinant factor VIII preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

Structure of human factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2009.02135.X

10.1111/J.1365-2516.2009.02135.X

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference